Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119537) titled 'A single-arm, single-center, phase II clinical study on microwave ablation combined with immune checkpoint inhibitors in the treatment of oligometastatic advanced gastric/gastroesophageal junction adenocarcinoma' on Feb. 28.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Fudan University Shanghai Cancer Center
Condition:
Gastric/Gastric Fundus Adenocarcinoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-02-28
Target Sample Size: Experimental Group:22;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html...